Dr. Ravi P. Sarma

Dr. Solmaz Sahebjam is a medical oncologist and an associate professor of oncology at Johns Hopkins University School of Medicine. Her expertise is in primary and metastatic brain tumors, breast cancer, and the development of new drugs for cancer. She earned her medical degree from Iran University of Medical Sciences, followed by a post-doctoral research fellowship at Shriners Hospital, McGill University in Montreal. Dr. Sahebjam completed residency training in internal medicine at Saint Vincent Hospital, followed by a fellowship in internal medicine at the University of Ottawa in Canada. She continued her training with a residency in medical oncology at McGill University in Canada followed by a fellowship in early-phase drug development, breast oncology, and neurooncology at Princess Margaret Hospital, University of Toronto in Canada. Dr. Sahebjam’s research is focused on the development of novel therapeutic regimens for the treatment of cancer including breast and central nervous system malignancies. Over the years, she has led and contributed to numerous clinical trials some of which have resulted in new treatment options for patients with cancer. Dr. Sahebjam is rated as an Elite provider by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Glioma, Brain Tumor, Glioblastoma, Astrocytoma, and Awake Craniotomy.

Neil Rosenshein is a Gynecologic Oncologist and an Oncologist in Baltimore, Maryland. Dr. Rosenshein is rated as a Distinguished provider by MediFind in the treatment of Hemangiopericytoma. His top areas of expertise are Angiomyoma, Uterine Fibroids, Ovarian Carcinosarcoma, Ureteroscopy, and Vaginectomy. Dr. Rosenshein is currently accepting new patients.

Amy Byer is an Obstetrics and Gynecologist and an Oncologist in Rockville, Maryland. Dr. Byer is rated as an Advanced provider by MediFind in the treatment of Hemangiopericytoma. Her top areas of expertise are Lichen Sclerosus, Female Genital Sores, Pelvic Inflammatory Disease, Menorrhagia, and Intrauterine Device Insertion. Dr. Byer is currently accepting new patients.